maillard reaction inhibitors (Quadrant)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemaillard reaction inhibitors (Quadrant)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsMaillard reaction inhibitors
TargetsUpdating
Therapy Area/IndicationsDiabetes ComplicationsCardiovascular DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuadrant Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuadrant Technologies Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsCardiovascular DiseasesAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A